HALO
Halozyme Therape (HALO)
NASDAQ
$69.35+$0.36 (+0.52%)
Price as of Jun 23, 2026 3:27 PM EDT
  • $8.2B
    Market Cap
  • 30.66%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$68.99
Change
+$0.44 (+0.64%)
Open
$69.34
High
$69.81
Low
$68.27
Previous Close
$68.55
Volume
1,054,256
30-Day Average Volume
1,821,799
1-Week Change
-3.21%
1-Month Change
0.98%
1-Year Change
30.66%
3-Year Change
94.72%
5-Year Change
60.26%
Fundamentals
Shares Outstanding
118.6M
Total Assets
$2.7B
Market Cap
$8.2B
Enterprise Value
$10.0B
Period:
QTR
TTM
FY
Revenue
$240.7M
Net Income
$150.0M
Free Cash Flow
$176.3M
EBIT
$180.7M
EBITDA
$210.2M
Net Working Capital
$639.8M
EPS
$1.22
Enterprise Value/EBITDA
48
Enterprise Value/Revenue
42
P/B
37
P/E
57
PEG
0
Price/Free Cash Flow
46
Price/Operating Cash Flow
45
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue